Double Medical Technology Inc (002901) — Working Capital to Net Assets Ratio
Double Medical Technology Inc (002901) has a Working Capital to Net Assets ratio of 68.5% as of March 2026. Working capital of CN¥2.64 Billion (current assets of CN¥3.46 Billion minus current liabilities of CN¥817.23 Million) is measured against net assets of CN¥3.85 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 002901 equity to assets ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Double Medical Technology Inc Working Capital to Net Assets (2013–2025)
This chart shows how Double Medical Technology Inc's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the ratio stands at 68.5%, reflecting working capital of CN¥2.64 Billion against net assets of CN¥3.85 Billion CNY. Check Double Medical Technology Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Double Medical Technology Inc (2013–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Double Medical Technology Inc from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Double Medical Technology Inc stock valuation.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 66.8% | CN¥2.46 Billion | CN¥3.69 Billion | CN¥3.34 Billion | CN¥878.18 Million | ▲ +8.0 pp |
| 2024 | 58.8% | CN¥1.87 Billion | CN¥3.18 Billion | CN¥2.81 Billion | CN¥941.40 Million | ▼ -4.5 pp |
| 2023 | 63.3% | CN¥2.00 Billion | CN¥3.16 Billion | CN¥3.16 Billion | CN¥1.15 Billion | ▼ -1.4 pp |
| 2022 | 64.7% | CN¥2.01 Billion | CN¥3.11 Billion | CN¥2.73 Billion | CN¥716.60 Million | ▲ +0.0 pp |
| 2021 | 64.6% | CN¥1.67 Billion | CN¥2.59 Billion | CN¥2.40 Billion | CN¥721.78 Million | ▼ -6.9 pp |
| 2020 | 71.6% | CN¥1.53 Billion | CN¥2.13 Billion | CN¥1.97 Billion | CN¥446.00 Million | ▲ +1.9 pp |
| 2019 | 69.7% | CN¥1.22 Billion | CN¥1.75 Billion | CN¥1.65 Billion | CN¥425.75 Million | ▼ -9.6 pp |
| 2018 | 79.2% | CN¥1.16 Billion | CN¥1.46 Billion | CN¥1.33 Billion | CN¥176.55 Million | ▼ -0.7 pp |
| 2017 | 80.0% | CN¥990.52 Million | CN¥1.24 Billion | CN¥1.11 Billion | CN¥117.80 Million | ▲ +20.5 pp |
| 2016 | 59.5% | CN¥345.15 Million | CN¥580.13 Million | CN¥452.24 Million | CN¥107.09 Million | ▲ +10.8 pp |
| 2015 | 48.7% | CN¥215.23 Million | CN¥441.78 Million | CN¥300.56 Million | CN¥85.33 Million | ▲ +20.1 pp |
| 2014 | 28.7% | CN¥78.61 Million | CN¥274.36 Million | CN¥337.89 Million | CN¥259.28 Million | ▼ -25.6 pp |
| 2013 | 54.2% | CN¥121.82 Million | CN¥224.61 Million | CN¥186.59 Million | CN¥64.77 Million | — |